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Background: National Institute for Health and Clinical Excellence (NICE) clinical guidelines and subsequent NICE
issued ‘recommendation reminders’ advocate discontinuing two fertility procedures and caesarean sections in
women with hepatitis. We assess whether NICE guidance in 2004 and recommendation reminders were associated
with a change in the rate of clinical procedures performed.
Methods: Routine inpatient Hospital Episode Statistics (HES) data were extracted from the HES database for 1st
April 1998 to 31st March 2010 using OPCS procedure codes for varicocele operations in infertile men, endometrial
biopsies in infertile women and caesarean sections in women with hepatitis B or C. We used Joinpoint regression
to identify points in time when the trend in procedure rates changed markedly, to identify any influence of the
release of NICE guidance.
Results: Between 1998-2010, planned caesarean sections in women with and without hepatitis B or C increased
yearly (annual percentage change (APC) 4.9%, 95% CI 2.1% to 7.7%) in women with hepatitis, compared with
women without (APC 4.0% [95% CI 2.7% to 5.3%] up to 2001, APC -0.6% [95% CI -2.8% to 1.8%] up to 2004 and
1.3% [95% CI 0.8% to 1.8%] up to 2010). In infertile women under 40 years of age, endometrial biopsies for
investigation of infertility increased, APC 6.0% (95% CI 3.6% to 8.4%) up to 2003, APC 1.5% (95% CI -4.3% to 7.7%) to
2007 followed by APC 12.8% (95% CI 1.0% to 26.0%) to 2010. Varicocele procedures remained relatively static
between 1998 and 2010 (APC -0.5%, 95% CI -2.3% to 1.3%).
Conclusions: There was no decline in use of the three studied procedures, contrary to NICE guidance, and no
change in uptake associated with the timing of NICE guidance or recommendation reminders. ‘Do not do’
recommendation reminders may be ineffective at improving clinical practice or achieving disinvestment.
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National Institute for Health and Clinical Excellence
(NICE) recommendation reminders identify practices
that should be discontinued where they are not evidence
based. These reminders, also known as optimal practice
reviews and the basis of the newer ‘do not do’ guidance
database, are drawn from NICE cancer service gui-
dance, clinical guidelines, interventional procedures and* Correspondence: charlotte.chamberlain@bristol.ac.uk
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distribution, and reproduction in any mediumtechnology appraisals guidance, and aim to help the
NHS make ‘better use of its resources [1].’ As of 2012,
there were 147 NICE recommendation reminders
(issued from 2000 to 2006) extracted from 34 different
NICE clinical guidelines and technology appraisals.
Fertility is the clinical area with the highest number of
recommendation reminders issued (22). Five reminders
pertain to caesarean section clinical guidelines. After the
2004 fertility and caesarean section NICE clinical guide-
lines (clinical guidelines 11 and 13, respectively), the
following recommendation reminders were released: (i)
caesarean sections are not indicated to reduce theentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[2]; (ii) the use of endometrial biopsies in the luteal
phase to investigate female infertility is not indicated [3];
(iii) the use of varicocele operations as a means to treat
infertility in men is not indicated [3]. The caesarean
section guideline has been updated (Nov 2011) with no
changes to the above recommendations.
The impact of these recommendation reminder prompts
has never been formally evaluated, although it is clear that
there is variable adherence to NICE clinical guidelines and
technology appraisals in a range of clinical practice areas
[4-10]. This paper assesses the impact of four NICE recom-
mendation reminders on the use of three procedures,
which should be discontinued according to the evidence
base. Our hypothesis is that NICE clinical guidelines and
reminders should precede a reduction in the trend of pro-
cedure uptake, in line with the best evidence.
Methods
Trends in procedure volume were assessed using routine,
freely available, English inpatient patient-level Hospital
Episode Statistics (HES) data [11] from the NHS informa-
tion Centre from 1st April 1998 to 31st March 2010 (each
HES year commences on 1st April and ends 31st March)
using relevant procedure codes (OPCS 4) stratified by the
designated ICD-10 diagnosis codes (Table 1) in all diagno-
ses. We included both primary and secondary procedureTable 1 ICD-10 and OPCS-4.5 procedure codes for HES data o
Recommendation reminder Publication
of original g
Caesarean Section: April 2004
Recommendation reminder 3: There is insufficient
evidence that planned caesarean reduces mother-to-child
transmission of hepatitis B virus when transmission can
be reduced by administration of immunoglobulin and
vaccination to the child.
Caesarean Section: April 2004
Recommendation reminder 4: Women who are infected
with hepatitis C should not be offered a planned caesarean
because this does not reduce mother-to-child transmission of
hepatitis C virus
Fertility: February 20
Recommendation reminder 1: Women should not be
offered an endometrial biopsy to evaluate the luteal
phase as part of the investigation of fertility problems
Fertility: February 20
Recommendation reminder 9: Men should not be
offered surgery for varicoceles as a form of fertility treatmentand diagnosis codes and included all episodes during a
hospital spell. We computed rates of planned and un-
planned caesarean sections per 100,000 deliveries, using
the total number of deliveries (OPCS-4 codes: R17 to
R25) [12] and women with hepatitis B and C combined.
We compared trends in caesarean section rates in women
with and without hepatitis over time using women with-
out hepatitis as an observational ‘control’. Similarly we
compared trends in unplanned and planned caesarean
section rates over time considering trends in the general
population.
We calculated the annual rate of endometrial biopsies
per 100,000 finished in-patient consultant episodes
(FCEs) for infertile women. The rates of endometrial
biopsy in women with a primary diagnosis of infertility
were stratified by age above or below 40 years (> 40,
≤ 40), as the primary indication for endometrial biopsies
above age 40 may have been investigations to rule out
endometrial cancer, rather than for luteal phase infertility.
Women with missing ages (1.8% of women under 40) were
excluded from the analysis. We conducted a sensitivity ana-
lysis to explore the impact on our conclusions of excluding
women without a primary diagnosis of infertility, where
endometrial biopsies may have been undertaken for an
alternative indication.
The rate of varicocele procedures per 100,000 finished
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primary or secondary diagnosis codes (up to 23 secon-
dary diagnosis codes) as exploratory analysis revealed
that some primary diagnosis codes were related to the
procedure itself (e.g. varices).
Joinpoint regression software (version 3.5.2 http://
surveillance.cancer.gov/joinpoint/) was used to identify
points in time when the trend in procedure rate changed
markedly, a so called ‘join point’. The annual rates of
procedure use over time were calculated as an annual
percentage change [APC]). The joinpoint analysis was
based on Poisson rates and allowed calculation of 95%
confidence intervals around the joinpoint date and the
APC. Joinpoint software compares models with se-
quential hypothesis testing using permutation tests and
Bayesian Information Criterion to generate different
numbers of join points and to determine the best-fit data
series [13]. The joinpoint data were assessed by testing
the null hypothesis of no difference between the slope of
each trend of annual rate of change segment against the
previous neighbouring segment. To identify the line of
best-fit with joinpoint the null and alternative hypotheses
significance levels are varied to achieve an overall signi-
ficance level of 0.05 (5%). We accounted for multiple
testing using an amended Bonferroni correction [13].
Results
Caesarean section in women with hepatitis
There were 5,546 births to women with either hepatitis
B or C between 1998 and 2010, of which 3,712 were
normal vaginal deliveries, 829 unplanned caesarean sec-
tions, 525 planned caesarean sections and the remainder
were instrumental, breech or unknown delivery method.
There were 10 caesareans in women with hepatitis B or
C in 1998, compared with 93 in 2010; the model-based
estimates suggest that the underlying planned caesareanFigure 1 Planned caesarean section deliveries in women with and witsection rate in women with hepatitis B or C increased by
4.9% annually (APC 4.9%, 95% CI 2.1% to 7.7%). Un-
planned caesarean sections in women with hepatitis B or
C increased at a slightly lower average of 2.9% per annum
(95% CI 0.3% to 5.6%) i.e. three more unplanned caesarean
sections per 100 deliveries each year. There was no
evidence of a change in the underlying trend of increased
uptake of planned or unplanned caesarean section delivery
in women with hepatitis when the NICE guidance was
published in 2004, nor at any time between 1998 and
2010 (Figure 1). Results were similar when hepatitis B and
C positive rates were calculated separately.
Women without hepatitis also experienced an overall
increased number of planned caesarean section delive-
ries, from 43,619 in 1998 to 63,007 in 2010. Women
without hepatitis had a lower annual model-based in-
crease in planned caesarean sections overall, compared to
women with hepatitis: APC 4.0% (95% CI 2.7% to 5.3%)
up to 2001, APC -0.6% (95% CI -2.8% to 1.8%) up to 2004
and APC 1.3% (95% CI 0.8% to 1.8%) up to 2010. Rates
for unplanned caesarean sections in women without hepa-
titis demonstrated a more gradual rise in procedures over
the twelve year period compared both with unplanned
caesarean sections in women with hepatitis and planned
caesarean sections in women without hepatitis. The
model-based average annual percent change was 1.9%
(95% CI 1.6 to 2.2) up to 2007, followed by a decreasing
rate up to 2010 (APC -1.3%, 95% CI -4.2 to 1.8). The esti-
mated year where the change in trend occurred
(joinpoint) could have occurred as early as 2004 or as late
as 2007 (95% CI, p = 0.046).
Endometrial biopsy for female infertility
Out of 137,028 admissions for female infertility (primary
diagnosis), 26,527 endometrial biopsies were performed
(19%) between 1998 and 2010. Although the number ofhout hepatitis B or C, compared with guidance release.
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40 years, (mean per year 2,210) compared with those
over 40 years (mean per year 338) the rate of procedures
was lower (15,430 per 100,000 compared with 21,356
per 100,000 admissions, respectively in 1998). In women
under 40 years, there is an absolute reduction in the
number of endometrial biopsies per year (2,859 to 2,162)
over the period; however, due to a concurrent reduction
in the number of admissions in this group, there was an
increase in the rate of endometrial biopsies over time.
The increasing rate fluctuated from an APC of 6.0%
(95% CI 3.6% to 8.4%), up to 2003 (with biopsy numbers
declining from 2859 to 2141); a slower increase of APC
1.5% (95% CI -4.3% to 7.7%) from 2003 to 2007; and a
faster rise in biopsies, APC 12.8% (95% CI 1.0% to
26.0%) between 2007 and 2010 (Figure 2). The 95%
confidence interval around the estimated year at which
change occurred suggests that the slowing of the upward
rate in procedures in 2003 could have occurred between
2000 and 2004 (95% CI, p-value 0.025) and the rapid
upward deflection in rate could have occurred as early
as 2005 (although the upper confidence interval remained
at 2007, p-value 0.05).
211,928 women with endometrial biopsies (79%) had
infertility as their primary diagnosis code, with remaining
primary diagnosis codes including recognised contributory
causes of infertility (pelvic adhesions 5,772 (2.1%), endo-
metriosis 3,103 (1.4%), polycystic ovarian syndrome 3,825
(1.4%) leiomyoma 3,570 (1.3%), in vitro fertilisation 3,805
(1.4%) and other diagnoses (all <1% each)). Sensitivity
analysis in women, where infertility was coded as either a
primary or secondary diagnosis, showed similar trends in
procedure rates.
Varicocele procedures for male infertility
Out of 9,399 finished consultant episodes for male infer-
tility (all diagnoses), 437 (4.6%) underwent varicocele
procedures over the twelve year period. There was no
appreciable change in procedure volume between 1998
and 2010 (Figure 3), starting from 49 procedures in 1998Figure 2 Endometrial biopsies in women > and < 40 years of age out
with the timing of NICE fertility guidelines.to 48 in 2010, with 5 fewer procedures for every 1000
men seen in hospital for infertility per annum (APC -0.5%,
95% CI -2.3% to 1.3%). Specifically, there was no change
in trend after NICE guidance.
Discussion
Main findings
The observed changes in the procedure rates over time
were not consistent with the decline in rates that would
be expected if English NHS trusts had responded to the
NICE “do not do” guidance. Between 1998 and 2010, the
proportion of deliveries performed by planned caesarean
section increased in all women, with a steeper increase
in women with hepatitis, against best-practice guidance.
Numbers of male varicocele procedures were low and
changed little during the study. The low procedure rate
may be a reflection of many clinicians being aware of,
and largely complying with, best practice before NICE
guidance was issued. However, as a ‘do not do’ guidance,
a decline even in the already low rate would have been
anticipated. Endometrial biopsy rates, on the other hand,
have shown an unexpected general increase in women
less than 40 years, with only a transient slowing between
2003 and 2007. This increase is present in both women
above and below 40 years and when infertility was used
in primary and secondary diagnosis codes. This increase
is contrary to guidance and shows no association with
the timing of the fertility guidance. Overall, there is no
good evidence that the release of the reminders had any
effect on the trends in clinical practice for any of the
procedures studied.
Strengths and limitations
This work should be interpreted in light of some limita-
tions, including difficulties extrapolating what trends
would have occurred in procedure rates had guidance
not been issued. We have partially overcome this for the
caesarean section analysis by looking at women without
hepatitis as an observational ‘control’ group. In addition,
by assessing three very different procedures we hope toof total finished consultant episodes for infertility, compared
Figure 3 Varicocele operations in infertile men compared with the timing of NICE fertility guidelines.
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may be secondary to other secular trends. Any change in
procedure trend, would not necessarily be caused by
NICE guidance, only temporally associated with it. We
are also unable to detect whether individual NHS trusts
are enacting NICE guidance, relying instead on nationally
collected evidence, which has shown that the guidance in
these clinical areas has not appreciably influenced the
trend in procedure performance. Any inference from this
national data to the local trust level would be subject to
ecological fallacy. Since the intention of the recommenda-
tion reminders and ‘do not do’ guidance is to effect a
reduction in clinical procedure uptake, however, we can
conclude, based on our study, that the guidelines appear
not to have had an effect, since none of the procedures
declined appreciably.
NICE does not record the date when recommendation
reminders are published, which is an additional limitation,
but since most observed changes in practice occurred
before the NICE clinical guidance release (February and
April 2004) and therefore, certainly before the recommen-
dation reminder which follows the guidance, this would
not alter our interpretation. There were two exceptions
where there were changes in trend after guidance was
issued: endometrial biopsies, which saw an increase in rate
in 2007, the opposite of guidance and the fall in un-
planned caesareans in women without hepatitis, which
was not the focus of the caesarean guidelines or recom-
mendation reminders. We are unable to account for any
changes over time in the accuracy of diagnostic coding,
but the consistency of our findings across three different
procedures suggests that our results and interpretation are
probably not due to coding anomalies changing over time.
More specific limitations, relevant to the clinical pro-
blems, include the fact that a caesarean section that occurs
in a woman with hepatitis may not be solely because of
the hepatitis B or C, but for a valid clinical reason, such as
a breech presentation. We have therefore compared rates
of planned and unplanned procedures in women with andwithout hepatitis to extrapolate, at an ecological level any
trend to offset this concern. While the hepatitis C
recommendation is a blanket ‘do not do’ guidance, the
recommendation reminder for hepatitis B advises against
planned caesarean section in women with hepatitis B on
the presumption that the neonate will receive vaccination
and immunoglobulin after birth. It is unlikely, therefore
that a planned caesarean would be arranged to prevent
mother-to-child transmission of hepatitis B in the UK,
where the vaccine and immunoglobulin are freely available
after birth.
To assess the quality of the HES data recording, we
have compared the number of pregnant women with
hepatitis B based on antenatal screening, with the num-
ber of hepatitis positive pregnant women in HES. The
total number of deliveries in women with hepatitis
coded in HES data was lower than the expected number
of women with hepatitis B, based on antenatal screening
(hepatitis B prevalence at antenatal clinic: 0.35% 2008;
women delivering with hepatitis according to HES data:
0.11% in 2008) [14]. This raises questions as to the
completeness of HES recording. This potential under-
recording in HES could only affect our results if real
reductions in caesarean section rates amongst women
with hepatitis B were masked because recording of
hepatitis B in women with caesarean section dramatic-
ally improved after 2004. The total numbers of women
giving birth coded in HES is comparable with national
epidemiological surveillance figures over the time period.
Our results show two procedures which have clear
upward trends in procedure uptake, despite guidance to
the contrary. The increasing trend in endometrial biop-
sies in women with infertility cannot be explained by
competing evidence outside the published guidelines
since there is good consensus in the peer-reviewed lite-
rature that endometrial biopsies are an ineffective means
of predicting fertility and therefore, should not be
conducted outside a research context [15]. We have
attempted to control for artefactual explanations for the
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above and below 40 years and by limiting the analysis to
only those women with infertility as their primary diag-
nosis, in case the biopsies are indicated for cancer
investigation rather than infertility. Despite best evidence,
the continued rise in planned caesarean section rates in
women with hepatitis, compared to women without hepa-
titis, illustrates the potential difficulties in implementing
disinvestment in this and other clinical guidelines where it
is possible clinicians may dispense with NICE guidance, in
favour of alternative evidence sources, such as published
systematic reviews or local experience to dictate best prac-
tice. Unlike the consensus in endometrial biopsy indications
amongst experts and the literature, there has been some
debate in the literature for caesarean sections in women
with hepatitis [16]. However, the updated NICE guidelines
(2011) [17] uphold the original position that planned cae-
sarean sections are not indicated for hepatitis status alone.
This work provides a clear evaluation of trends in
three sub populations, in which procedures were iden-
tified as areas for potential disinvestment. Successful
disinvestment from ineffective care is crucial if the NHS
is to respond successfully to the current pressures on
public funding. Our analysis uses twelve years of HES
data [18] to describe changes in clinical practice that
might be associated with NICE guidance for evidence
based practice. Previous publications evaluating the imple-
mentation of NICE guidance, both those commissioned
by NICE [8] and reported independently [10] were in
2005 and 2004 respectively and therefore, this is a timely
update in light of the changing responsibilities of NICE
[19]. The past literature focuses on NICE ‘technology
appraisals’, which historically carried a mandatory funding
requirement for commissioners, rather than the non-
mandatory clinical guidelines [8,10]. Numerous eva-
luations of NICE implementation have revealed ‘under
implementation’ of guidance [4,8]. Of those specifically
assessing disinvestment decisions (two of the 45 imple-
mentation uptake reports) one has shown a decline in
accordance with NICE guidance [20], the other a conti-
nued increase in drug prescribing, despite guidance [21].
Therefore, NICE may not only produce an insufficient
number of disinvestment guidelines [22], but also have
minimal evidence of their implementation.
Conclusions
Our finding that the three studied procedures are not
decreasing in line with NICE recommendations indicates
a persistent research question around how best to imple-
ment NICE guidance and in particular, NICE disinvest-
ment advice. Despite an increasing effort on behalf of
NICE to introduce guidance implementation tracking, and
the introduction of programmes to assist NHS Trusts in
implementing evidence-based recommendations, there isstill no clear steer on how to translate best evidence guide-
lines into best practice [23-25]. Clinical practice decisions
are influenced by a number of factors including relevant
literature, clinical guidelines, peer or senior support, as
well as the policy environment [10,23-25]. The failure to
implement recommendation reminders, which highlight
areas for disinvestment, has particular implications both
for clinical and cost effectiveness. Further study to supple-
ment our understanding of other barriers to disinvestment
could include the use of mixed methodology study with
qualitative interviews exploring clinician engagement with
disinvestment guidelines, and audit and prescribing data,
which would counteract some of the missing data in the
HES database [26]. Recommendation reminders have no
demonstrable association with clinical practice nationally
for the three procedures evaluated in this study and there-
fore, they may be an ineffective means to bring about
disinvestment and change across England.
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